Posted on 11/15/2021 10:26:10 AM PST by Red Badger
A British company is moving towards phase 1 trials for its novel Covid-19 vaccine, which is applied as a skin patch and uses T-cells to fight back against the virus. In theory it offers longer-lasting protection. Speaking to The Guardian in an article published on Monday, Emergex Chief Commercial Officer Robin Cohen hailed the awarding of regulatory approval by Swiss authorities for allowing his Oxfordshire-based firm to push forward with the clinical trials.
Cohen stated that it was the first time a regulator had approved a Covid-19 vaccine for clinical trials in which the vaccine’s sole purpose was to “generate a targeted T-cell response” rather than an antibody response.
While the antibody response, engendered by overcoming infection or the administration of one of the current cohorts of widely used vaccines, wanes over time, the Emergex skin patch could offer longer-lasting immunity – possibly for decades, according to Cohen.
The COO claimed that the vaccine could be more effective too. Research published last week described a so-called “abortive infection” in which T-cells destroy the virus before it has the chance to settle in the body.
However, Danny Altmann, a professor of immunology at Imperial College London, told the Guardian that a T-cell vaccine was unlikely to be capable of providing complete cover against the virus, suggesting it could be used to complement an existing vaccine that generates an antibody response.
Altmann noted that the Pfizer vaccine elicits a weaker T-cell response than the AstraZeneca shot, but the former is considered more effective against Covid-19.
Emergex’s skin patch vaccine will start its trial on January 3 after the Swiss drugs regulator granted approval for the 26-person test. Interim results from the trial are expected in June with some participants receiving higher doses than others.
Cohen added that the skin patch vaccine would not be available until 2025 at the earliest, noting the normal timeframe for vaccine development.
While current Covid-19 vaccines are administered by injection, some in development will be administered in pill form and nasal applicators. In a number of cases, a dearth of syringes has slowed the administration of vaccines.
They probably want an injection that will kill more faster.
Make an oral vaccine out of bacon and the line will be miles long.
As I have said in the past, There will never be an end to this “so called covid-19 as long as there is a democrat alive. There is NO WAY AMERICA IS EVER GOING BACK TO “NORMAL.”
Does this one meet the old definition of a vaccine or the modified new definition.
Totally different form either one.....................
So the Fauci/CCP biological warfare virus requires vaccines forever and ever Amen?
yeah
others can be guinea pigs
good scientists and doctors don’t hate the control groups
that’s not “science”
Woild cost too much... have you seen the price of bacon lately?
**
As if ModeRNA & Pfizer would allow an upstart company to stop their Covid gravy train.
In theory...
What I never seem to read is any research into stopping viruses from mutating. They are always chasing the latest mutation like yearly flu shots with their best guess.
Good point. There goes another billion dollar idea down the tubes.
We hear a lot about antibodies waning after 6 months. But what happens to T-Cell response?
Clearly T-Cell response is not as robust as we would like or fewer of the vaccinated would be getting sick. But I’ve not seen reporting on t-cells.
OMG
I have to get in on this gold mine...
Nope.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.